Nacubactam has some intrinsic antibacterial action because of PBP2 inhibition [141]. It appears to possess superior in vivo activity from AmpC-overproducing and Klebsiella pneumoniae Use our demo look for to discover descriptions of medical trials, taking part trial clinics, their recruitment status and results. Period 3 trials showed excellent efficacy https://joschkax232pcn6.oneworldwiki.com/user